ATAGI recommendation on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.
09
Oct
ATAGI recommendation on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised.
A joint statement from the Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca.
ATAGI has released a number of recommendations relating to the COVID-19 Vaccine.